Neuroalojen ja kuntoutuksen vastuualue

Julkaisut 2012
Publications 2012

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alapirtti T et al. C-reactive protein and seizures in focal epilepsy: a video-electroencephalographic study.
2 Bäck L et al. The developing management of esthesioneuroblastoma: a single institution experience.
3 Cardani R et al. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
4 Elas N et al. Spanish MYH7 founder mutation of Italian ancestry causing a large cluster of Laing myopathy patients.
5 Hakulinen U et al. Repeatability and variation of region-of-interest methods using quantitative diffusion tensor MR imaging of the brain.
6 Haroun OM et al. Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study.
7 Hartikainen KM et al. Orbitofrontal cortex biases attention to emotional events.
8 Hartikainen KM et al. Threat interferes with response inhibition.
9 Isotalo K et al. Upstream Transcription Factor 1 (USF1) Polymorphisms Associate with Alzheimer's Disease-related Neuropathological Lesions: Tampere Autopsy Study.
10 Iverson GL et al. Outcome from Complicated versus Uncomplicated Mild Traumatic Brain Injury.
11 Jehkonen M et al. Driving ability in stroke patients with residual visual inattention: A case study.
12 Jokela M et al. Double trouble: spinal muscular atrophy type II and seropositive myasthenia gravis in the same patient.
13 Kettunen JE et al. The presence of visual neglect after thrombolytic treatment in patients with right hemisphere stroke.
14 Kuusisto H et al. Volumetric MRI assessment of brain and spinal cord in Finnish twins discordant for multiple sclerosis.
15 Laitila J et al. Expression of multiple nebulin isoforms in human skeletal muscle and brain.
16 Liimatainen S, Peltola J. Epilepsy associated with glutamic acid decarboxylase antibody (GADA).
17 Losoi H et al. Predictors of functional outcome after right hemisphere stroke in patients with or without thrombolytic treatment.
18 Mentula HK et al. TARDBP mutations are not a frequent cause of ALS in Finnish patients.
19 Mäkelä K et al. Complement activation in astrocytomas: deposition of C4d and patient outcome.
20 Natarajan R et al. Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
21 Ohlsson M et al. Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin.
22 Pan PW et al. Brain phenotype of carbonic anhydrase IX-deficient mice.
23 Penttilä S et al. Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2.
24 Penttilä S et al. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.
25 Pfeffer G et al. Titin mutation segregates with hereditary myopathy with early respiratory failure.
26 Pyysalo L. Long-term outcome of patients with embolized intracranial aneurysms.
27 Raheem O. Molecular basis of myotonic disorders and new diagnostic techniques.
28 Raheem O et al. New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics.
29 Renard D et al. Camptocormia as presenting sign in myofibrillar myopathy.
30 Saarinen JT et al. The mid-M1 segment of the middle cerebral artery is a cutoff clot location for good outcome in intravenous thrombolysis.
31 Sarparanta J et al. Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.
32 Sillanpää N. Multimodal computed tomography in the evalution of acute ischemic stroke.
33 Sillanpää N et al. Comparison of 64-row and 16-row multidetector CT in the perfusion CT evaluation of acute ischemic stroke patients receiving intravenous thrombolytic therapy.
34 Sillanpää N et al. The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapy.
35 Soilu-hänninen M et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon ß-1b in patients with multiple sclerosis.
36 Suokas K et al. Pain in patients with myotonic dystrophy type 2: a postal survey in Finland.
37 Tasca G et al. Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia.
38 Tasca G et al. New phenotype and pathology features in MYH7-related distal myopathy.
39 Tyynismaa H et al. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.
40 Udd B. Distal myopathies--new genetic entities expand diagnostic challenge.
41 Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
42 Wäljas M et al. Reliability, validity and clinical usefulness of the BNI fatigue scale in mild traumatic brain injury.
Julkaisutietokanta 11.12.2013 Publications Data Base 11.12.2013